Stay updated on Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedThe Locations section now lists multiple study sites across the United States (California, Connecticut, District of Columbia, Illinois, Massachusetts, New Jersey, New York, Oregon, Pennsylvania, Wisconsin) and Navarre, Spain.SummaryDifference0.9%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew labels in Study Record Dates show 'Results First Posted (Estimated)' and 'Last Update Posted (Estimated)' and the page shows 'Revision: v3.3.2'; these are metadata/display changes that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded a Results Posted section detailing Stage 1 efficacy outcomes (ORR, PFS, OS, DOR, DC) with RECIST v1.1 definitions and the 'Results First Posted' metadata. Removed several older endpoint descriptions and timing details from the results reporting.SummaryDifference2%

- Check40 days agoChange DetectedThe page now displays a new 'Results Submitted' banner and removes the 'No Results Posted' notice, updating the study record's results reporting status.SummaryDifference0.3%

- Check55 days agoChange DetectedNo significant changes detected between the old and new screenshots; the study details and structure remain the same.SummaryDifference0.3%

- Check83 days agoChange DetectedCore content updated with a government funding notice and a new version number (v3.2.0) replacing the old v3.1.0.SummaryDifference2%

Stay in the know with updates to Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page.